Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects

NCT01543490 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

558

Enrollment

INDUSTRY

Sponsor class

Conditions

Active, Symptomatic Blepharitis

Interventions

DRUG: ISV-305
OTHER: Vehicle

Sponsor

Sun Pharmaceutical Industries Limited